The global peptide therapeutics market size is calculated at USD 52.59 billion in 2025 and is forecasted to reach around USD 83.75 billion by 2034, accelerating at a CAGR of 5.31% from 2025 to 2034. The North America peptide therapeutics market size surpassed USD 22.58 billion in 2024 and is expanding at a CAGR of 5.26% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Peptide Therapeutics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Peptide Therapeutics Market, by Application
8.1.1. Gastrointestinal Disorder
8.1.1.1. Market Revenue and Forecast
8.1.2. Metabolic Disorder
8.1.2.1. Market Revenue and Forecast
8.1.3. Neurological Disorder
8.1.3.1. Market Revenue and Forecast
8.1.4. Cancer
8.1.4.1. Market Revenue and Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Forecast
9.1. Peptide Therapeutics Market, by Type
9.1.1. Generic
9.1.1.1. Market Revenue and Forecast
9.1.2. Innovative
9.1.2.1. Market Revenue and Forecast
10.1. Peptide Therapeutics Market, by Route of Administration
10.1.1. Oral
10.1.1.1. Market Revenue and Forecast
10.1.2. Parenteral
10.1.2.1. Market Revenue and Forecast
10.1.3. Pulmonary
10.1.3.1. Market Revenue and Forecast
10.1.4. Mucosal
10.1.4.1. Market Revenue and Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Forecast
11.1. Peptide Therapeutics Market, by Distribution Channel
11.1.1. Hospital Pharmacies
11.1.1.1. Market Revenue and Forecast
11.1.2. Retail Pharmacies
11.1.2.1. Market Revenue and Forecast
11.1.3. Online Drug Stores
11.1.3.1. Market Revenue and Forecast
12.1. Peptide Therapeutics Market, by Synthesis Technology
12.1.1. Solid Phase peptide Synthesis (SPPS)
12.1.1.1. Market Revenue and Forecast
12.1.2. Liquid Phase Peptide Synthesis (LPPS)
12.1.2.1. Market Revenue and Forecast
12.1.3. Hybrid Technology
12.1.3.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Application
13.1.2. Market Revenue and Forecast, by Type
13.1.3. Market Revenue and Forecast, by Route of Administration
13.1.4. Market Revenue and Forecast, by Distribution Channel
13.1.5. Market Revenue and Forecast, by Synthesis Technology
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Application
13.1.6.2. Market Revenue and Forecast, by Type
13.1.6.3. Market Revenue and Forecast, by Route of Administration
13.1.6.4. Market Revenue and Forecast, by Distribution Channel
13.1.6.5. Market Revenue and Forecast, by Synthesis Technology
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Application
13.1.7.2. Market Revenue and Forecast, by Type
13.1.7.3. Market Revenue and Forecast, by Route of Administration
13.1.7.4. Market Revenue and Forecast, by Distribution Channel
13.1.7.5. Market Revenue and Forecast, by Synthesis Technology
13.2. Europe
13.2.1. Market Revenue and Forecast, by Application
13.2.2. Market Revenue and Forecast, by Type
13.2.3. Market Revenue and Forecast, by Route of Administration
13.2.4. Market Revenue and Forecast, by Distribution Channel
13.2.5. Market Revenue and Forecast, by Synthesis Technology
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Application
13.2.6.2. Market Revenue and Forecast, by Type
13.2.6.3. Market Revenue and Forecast, by Route of Administration
13.2.7. Market Revenue and Forecast, by Distribution Channel
13.2.8. Market Revenue and Forecast, by Synthesis Technology
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Application
13.2.9.2. Market Revenue and Forecast, by Type
13.2.9.3. Market Revenue and Forecast, by Route of Administration
13.2.10. Market Revenue and Forecast, by Distribution Channel
13.2.11. Market Revenue and Forecast, by Synthesis Technology
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Application
13.2.12.2. Market Revenue and Forecast, by Type
13.2.12.3. Market Revenue and Forecast, by Route of Administration
13.2.12.4. Market Revenue and Forecast, by Distribution Channel
13.2.13. Market Revenue and Forecast, by Synthesis Technology
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Application
13.2.14.2. Market Revenue and Forecast, by Type
13.2.14.3. Market Revenue and Forecast, by Route of Administration
13.2.14.4. Market Revenue and Forecast, by Distribution Channel
13.2.15. Market Revenue and Forecast, by Synthesis Technology
13.3. APAC
13.3.1. Market Revenue and Forecast, by Application
13.3.2. Market Revenue and Forecast, by Type
13.3.3. Market Revenue and Forecast, by Route of Administration
13.3.4. Market Revenue and Forecast, by Distribution Channel
13.3.5. Market Revenue and Forecast, by Synthesis Technology
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Application
13.3.6.2. Market Revenue and Forecast, by Type
13.3.6.3. Market Revenue and Forecast, by Route of Administration
13.3.6.4. Market Revenue and Forecast, by Distribution Channel
13.3.7. Market Revenue and Forecast, by Synthesis Technology
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Application
13.3.8.2. Market Revenue and Forecast, by Type
13.3.8.3. Market Revenue and Forecast, by Route of Administration
13.3.8.4. Market Revenue and Forecast, by Distribution Channel
13.3.9. Market Revenue and Forecast, by Synthesis Technology
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Application
13.3.10.2. Market Revenue and Forecast, by Type
13.3.10.3. Market Revenue and Forecast, by Route of Administration
13.3.10.4. Market Revenue and Forecast, by Distribution Channel
13.3.10.5. Market Revenue and Forecast, by Synthesis Technology
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Application
13.3.11.2. Market Revenue and Forecast, by Type
13.3.11.3. Market Revenue and Forecast, by Route of Administration
13.3.11.4. Market Revenue and Forecast, by Distribution Channel
13.3.11.5. Market Revenue and Forecast, by Synthesis Technology
13.4. MEA
13.4.1. Market Revenue and Forecast, by Application
13.4.2. Market Revenue and Forecast, by Type
13.4.3. Market Revenue and Forecast, by Route of Administration
13.4.4. Market Revenue and Forecast, by Distribution Channel
13.4.5. Market Revenue and Forecast, by Synthesis Technology
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Application
13.4.6.2. Market Revenue and Forecast, by Type
13.4.6.3. Market Revenue and Forecast, by Route of Administration
13.4.6.4. Market Revenue and Forecast, by Distribution Channel
13.4.7. Market Revenue and Forecast, by Synthesis Technology
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Application
13.4.8.2. Market Revenue and Forecast, by Type
13.4.8.3. Market Revenue and Forecast, by Route of Administration
13.4.8.4. Market Revenue and Forecast, by Distribution Channel
13.4.9. Market Revenue and Forecast, by Synthesis Technology
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Application
13.4.10.2. Market Revenue and Forecast, by Type
13.4.10.3. Market Revenue and Forecast, by Route of Administration
13.4.10.4. Market Revenue and Forecast, by Distribution Channel
13.4.10.5. Market Revenue and Forecast, by Synthesis Technology
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Application
13.4.11.2. Market Revenue and Forecast, by Type
13.4.11.3. Market Revenue and Forecast, by Route of Administration
13.4.11.4. Market Revenue and Forecast, by Distribution Channel
13.4.11.5. Market Revenue and Forecast, by Synthesis Technology
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Application
13.5.2. Market Revenue and Forecast, by Type
13.5.3. Market Revenue and Forecast, by Route of Administration
13.5.4. Market Revenue and Forecast, by Distribution Channel
13.5.5. Market Revenue and Forecast, by Synthesis Technology
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Application
13.5.6.2. Market Revenue and Forecast, by Type
13.5.6.3. Market Revenue and Forecast, by Route of Administration
13.5.6.4. Market Revenue and Forecast, by Distribution Channel
13.5.7. Market Revenue and Forecast, by Synthesis Technology
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Application
13.5.8.2. Market Revenue and Forecast, by Type
13.5.8.3. Market Revenue and Forecast, by Route of Administration
13.5.8.4. Market Revenue and Forecast, by Distribution Channel
13.5.8.5. Market Revenue and Forecast, by Synthesis Technology
14.1. Eli Lilly & Company
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Amgen Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Pfizer, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Ever Neuro Pharma GmbH
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Bausch Health
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Abbvie
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample